The Valley Desk

NCT00819780 · Interventional trial

PEAK: Panitumumab Plus mFOLFOX6 vs. Bevacizumab Plus mFOLFOX6 for First Line Treatment of Metastatic Colorectal Cancer (mCRC) Patients With Wild-Type Kirsten Rat Sarcoma-2 Virus (KRAS) Tumors

Overall registry status Completed

Phase 2

Conditions Colon Cancer, Colorectal Cancer, Metastatic Colorectal Cancer, Rectal Cancer

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov